Reach Us +1 218 451 2974
Aspartate Transcarbamylase | OMICS International
ISSN: 2168-9652
Biochemistry & Physiology: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Aspartate Transcarbamylase

Mahmoud Balbaa*
Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria, Egypt
Corresponding Author : Mahmoud Balbaa
Department of Biochemistry, Faculty of Science, Alexandria University
Alexandria, Egypt
E-mail: [email protected]
Received: October 26, 2015; Accepted: October 27, 2015; Published: November 03, 2015
Citation: Balbaa M (2015) Aspartate Transcarbamylase. Biochem Physiol 4:e142. doi:10.4172/2168-9652.1000e142
Copyright: © 2015 Balbaa M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Biochemistry & Physiology: Open Access

Aspartate Transcarbamylase (ATCase) EC is an important enzyme for catalyzing the first step of the biosynthesis of pyrimidine nucleotides [1]. It catalyzes the transfer of the carbamoyl group of carbamoyl phosphate as a donor to the amino acid aspartate as an acceptor to form carbamoyl aspartate [2]. There is an evidence that the mammalian enzyme is a member of a multifunctional complex called CAD that is responsible for the catalysis of the initial steps of this synthetic process [1,3]. In fact, the bacterial ATCase from E. coli is allosterically inhibited by the nucleotides cytidine triphosphate, uridine triphosphate and deoxy-cytidine triphosphate [1,4]. This allosteric behavior is missed in the mammalian ATCase as reported in the investigation of this enzyme from rat liver [5], whereas it obeys the conventional kinetic behavior of Michaelis and Menten assumption [6]. However, it was reported that the mammalian enzyme is inhibited by uridine monophosphate and 5-bromouridine [7], a phenobarbital derivative [6] and some quinazolinone compounds [8]. Recently, it was found that both the bacterial and mammalin enzymes are in vitro and inv vivo inhibited by the phenobarbital analogues thymidine, phenobarbital and thiobarbituric acid [9]. This inhibition is valuable for the regulation of pyrimidine nucleotide biosynthesis. It will be promising for the control of the growth of cancer cells since some ATCase inhibitors are considered as anti-proliferative compounds [10,11].
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12235
  • [From(publication date):
    December-2015 - Jun 27, 2019]
  • Breakdown by view type
  • HTML page views : 8419
  • PDF downloads : 3816